Jefferies continues to rate Pfizer (NYSE: PFE) as a Buy because they feel that the company has great potential for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE